Quantcast

Latest Acamprosate Stories

e258035c69ee0c005534d0c9997de3a41
2009-01-26 11:55:00

U.S. researchers said on Sunday that at least one in five men in developed countries are at risk of abusing or becoming dependent on alcohol during their lifetimes. Women, on the other hand, have only half that risk, with an 8 to 10 percent chance of becoming dependent on alcohol. The researchers said there is help in the form of several effective treatments, despite the popular belief that nothing works. Dr. Marc Schuckit of the Veterans Affairs San Diego Healthcare System and the University...

2008-08-13 15:00:00

The FDA has warned of the risk of injection site reactions to Vivitrol, a once-monthly injection drug for the treatment of alcohol dependence. However, due to the considerable adverse health consequences related to alcohol dependence, along with the limited number of prescription drugs available, Datamonitor does not expect Vivitrol to experience a substantial downturn in sales. Vivitrol (extended release naltrexone from Alkermes/Cephalon), an opioid antagonist launched in June 2006 for the...

2007-09-17 09:00:44

FARMINGTON, Conn., Sept. 17 /PRNewswire-USNewswire/ -- Coinciding with National Recovery Month (September), NAABT, Inc. proudly announces the launch of http://www.alcoholanswers.org/ AlcoholAnswers.org is an Evidence-based Resource Website providing educational information on Alcohol Abuse and Alcohol Dependence (Alcoholism). What is Evidence-based? Evidence-based thinking is a process by which diverse sources of information (research, theory, practice principles, practice guidelines,...

2006-05-03 07:15:00

CHICAGO (Reuters) - One of two drugs approved for use to curb alcoholics' cravings worked slightly better than specialized counseling, but a second drug on the market was no better than a placebo, according to a study of alcoholics released on Tuesday. Naltrexone, sold generically in daily pill form under the brand name ReVia by Barr Pharmaceuticals Inc., was effective, while acamprosate, marketed under the brand name Campral by Forest Laboratories Inc., was not. "We were surprised by two...

2006-05-02 16:09:10

CHICAGO (Reuters) - One of two drugs approved for use to curb alcoholics' cravings worked slightly better than specialized counseling, but a second drug on the market was no better than a placebo, according to a study of alcoholics released on Tuesday. Naltrexone, sold generically in daily pill form under the brand name ReVia by Barr Pharmaceuticals Inc., was effective, while acamprosate, marketed under the brand name Campral by Forest Laboratories Inc., was not. "We were surprised...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related